Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy

D'Addio, F.; La Rosa, S.; Maestroni, A.; Jung, P.; Orsenigo, E.; Ben Nasr, M.; Tezza, S.; Bassi, R.; Finzi, G.; Marando, A.; Vergani, A.; Frego, R.; Albarello, L.; Andolfo, A.; Manuguerra, R.; Viale, E.; Staudacher, C.; Corradi, D.; Batlle, E.; Breault, D.; Secchi, A.; Folli, F.; Fiorina, P.

doi:10.1016/j.stem.2015.07.010

Summary The role of circulating factors in regulating colonic stem cells (CoSCs) and colonic epithelial homeostasis is unclear. Individuals with long-standing type 1 diabetes (T1D) frequently have intestinal symptoms, termed diabetic enteropathy (DE), though its etiology is unknown. Here, we report that T1D patients with DE exhibit abnormalities in their intestinal mucosa and CoSCs, which fail to generate in vitro mini-guts. Proteomic profiling of T1D+DE patient serum revealed altered levels of insulin-like growth factor 1 (IGF-I) and its binding protein 3 (IGFBP3). IGFBP3 prevented in vitro growth of patient-derived organoids via binding its receptor TMEM219, in an IGF-I-independent manner, and disrupted in vivo CoSC function in a preclinical DE model. Restoration of normoglycemia in patients with long-standing T1D via kidney-pancreas transplantation or in diabetic mice by treatment with an ecto-TMEM219 recombinant protein normalized circulating IGF-I/IGFBP3 levels and reestablished CoSC homeostasis. These findings demonstrate that peripheral IGF-I/IGFBP3 controls CoSCs and their dysfunction in DE.

Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy / F. D'Addio, S. La Rosa, A. Maestroni, P. Jung, E. Orsenigo, M. Ben Nasr, S. Tezza, R. Bassi, G. Finzi, A. Marando, A. Vergani, R. Frego, L. Albarello, A. Andolfo, R. Manuguerra, E. Viale, C. Staudacher, D. Corradi, E. Batlle, D. Breault, A. Secchi, F. Folli, P. Fiorina. - In: CELL STEM CELL. - ISSN 1934-5909. - 17:4(2015), pp. 486-498.

Titolo:	Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy
Autori:	D'ADDIO, FRANCESCA S. La Rosa MAESTRONI, ANNA MARIA P. Jung E. Orsenigo BEN NASR, MOUFIDA S. Tezza R. Bassi G. Finzi A. Marando VERGANI, ANNA R. Frego L. Albarello A. Andolfo R. Manuguerra E. Viale STAUDACHER, CARLO D. Corradi E. Batlle D. Breault A. Secchi FOLLI, FRANCO FIORINA, PAOLO (Ultimo) (Corresponding) mostra contributor esterni nascondi contributor esterni
Parole Chiave:	colonic stem cells; diabetic enteropathy; diabetic nephropathy; hyperglycemia; IGF-I; IGFBP3; kidney transplantation; pancreas transplantation; type 1 diabetes; type 2 diabetes; uremia; cell biology; molecular medicine; genetics
Settore Scientifico Disciplinare:	Settore MED/09 - Medicina Interna Settore MED/13 - Endocrinologia
Data di pubblicazione:	2015
Rivista:	CELL STEM CELL
Tipologia:	Article (author)
Digital Object Identifier (DOI):	http://dx.doi.org/10.1016/j.stem.2015.07.010
Appare nelle tipologie:	01 - Articolo su periodico

File in questo prodotto:

File	Descrizione	Tipologia	Licenza
1-s2.0-S1934590915003094-main.pdf		Publisher's version/PDF		Administrator Richiedi una copia

Pubblicazioni consigliate

Loading suggested articles...

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/2434/469704

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

File in questo prodotto:

Pubblicazioni consigliate